G826-0823 Screening compound: 2-(4-{[(4-chlorophenyl)methyl]carbamoyl}piperidin-1-yl)-N-(2-fluorophenyl)pyridine-4-carboxamide

G826-0823 Screening compound: 2-(4-{[(4-chlorophenyl)methyl]carbamoyl}piperidin-1-yl)-N-(2-fluorophenyl)pyridine-4-carboxamide
G826-0823 Screening compound: 2-(4-{[(4-chlorophenyl)methyl]carbamoyl}piperidin-1-yl)-N-(2-fluorophenyl)pyridine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G826-0823
2-(4-{[(4-chlorophenyl)methyl]carbamoyl}piperidin-1-yl)-N-(2-fluorophenyl)pyridine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G826-0823

Molecular Formula

C25H24ClFN4O2 (C25 H24 ClFN4 O2)

Compound Name

2-(4-{[(4-chlorophenyl)methyl]carbamoyl}piperidin-1-yl)-N-(2-fluorophenyl)pyridine-4-carboxamide

IUPAC name

2-(4-{[(4-chlorophenyl)methyl]carbamoyl}piperidin-1-yl)-N-(2-fluorophenyl)pyridine-4-carboxamide

SMILES

O=C(C(CC1)CCN1c1nccc(C(Nc(cccc2)c2F)=O)c1)NCc(cc1)ccc1Cl

InChI

InChI=1S/C25H24ClFN4O2/c26-20-7-5-17(6-8-20)16-29-24(32)18-10-13-31(14-11-18)23-15-19(9-12-28-23)25(33)30-22-4-2-1-3-21(22)27/h1-9,12,15,18H,10-11,13-14,16H2,(H,29,32)(H,30,33)

InChI Key

AKAHFJVKFBQIAU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15039438

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

466.94

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.310

Distribution Coefficient, logD

4.309

Water Solubility, LogSw

-4.70

Polar Surface Area

59.009

Acid Dissociation Constant (pKa)

10.12

Base Dissociation Constant (pKb)

8.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

G826-0823 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

CNS Targets (44014 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with G826-0823 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G826-0823?
Check Price and Availability of G826-0823, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G826-0823 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G826-0823
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G826-0823
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G826-0823 available by request